BMS International Advisory Council
The Biomedical Sciences International Advisory Council (BMS IAC) serves the following functions:
- Shares perspectives and insights
- Advises Singapore on major global trends in biomedical research and industry
- Critiques and advises Singapore on its BMS initiatives.
They comprise eminent international scientists and visionaries in the biomedical field. The Council Members are:
Chairman
 |
Chairman, BMS IAC (2000-)
Chairman of UK Stem Cell Foundation (2010-)
Chairman of NHS London (2008-2010)
Distinguished Research Fellow, Imperial College London (2008)
Rector, Imperial College of Science, Technology & Medicine, UK (2001-2007)
Chairman, Glaxo Wellcome plc (1997-2002) |
Members
 |
Acting Co-Chairman, BMS IAC (2008-)
Senior Fellow of A*STAR
Senior Fellow at the Janelia Farm Research Campus of the Howard Hughes Medical Institute (HHMI)
Distinguished Professor, The Salk Institute for Biological Studies, USA (2000-)
Co-Chairman, Biomedical Sciences (BMS) International Advisory Council (IAC) (2000-2004)
2002 Winner of the Nobel Prize in Physiology or Medicine
President and Director of Science, Molecular Sciences Institute in Berkeley, CA, USA (1996-2001)
Director, MRC Lab of Molecular Biology (1979-1986) and MRC Molecular Genetics Unit (1986-1991), UK |
| |
|
 |
Member, BMS IAC (2008 - )
Vice Chancellor, University of Cambridge, (2010-)
Chief Executive, Medical Research Council UK, (2007-2010) |
| |
|
 |
Member, BMS IAC (2003-)
President, Australian Academy of Science (2010-)
Professor, Molecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Australia (1996-)
President, Australian Academy of Science (2010-) |
| |
|
 |
Member, BMS IAC (2008-)
Chief Medical Officer for England (2011-)
Director General for Research and Development, Department of Health (2005-2011) |
| |
|
 |
Dr Jack Dixon
Member, BMS IAC (2010-)
Vice President and Chief Scientific Officer
Howard Hughes Medical Institute |
| |
|
 |
Member, BMS IAC (2006-)
Director, Eugene McDermott Center Human Growth and Development
University of Texas Southwestern Medical Center (USA) (2000-)
Investigator, Howard Hughes Medical Institute (2002-)
Chief, Division of Medical Genetics, University of Texas Southwestern (UTSW) Medical Center (1987-) |
| |
|
 |
Member, BMS IAC (2008-)
Professor of Medicine
University of Pennsylvania, School of Medicine |
| |
 |
Member, BMS IAC (2006-)
Distinguished Investigator, Samuel Lunenfeld Research Institute of Mount Sinai Hospital (1985-)
Director of Research, Samuel Lunenfeld Research Institute of Mount Sinai Hospital (2001-2005) |
| |
|
 |
Member, BMS IAC (2004-)
President, Karolinska Institute, Sweden (2004-)
Dean and Chairwoman, Board of Research, Sweden (1999-2001)
Secretary General (2001-2003), and Asst. Secretary General (1996-1998),
Swedish Research Council Scientific Council for Medicine |
| |
|
 |
Member, BMS IAC (2006-)
Executive Vice-President and Board Member, Takeda Pharmaceuticals (2011-) |
| |
|
 |
Member, BMS IAC (2006-)
Professor & Chair, Institute of Experimental Immunology, University Hospital Zurich (1992-) |
| |
|
 |
Member, BMS IAC (2011-)
President, World Health Summit Charite Berlin (2011-)
Chairman of the Board, Charite Foundation (2005-) |
| |
|
 |
Member, BMS IAC (2011-)
Chief Executive, UK Medical Research Council (2010-)
Vice Principal and Head of the College of Medicine and Veterinary Medicine, University of Edinburgh (2002-) |
| |
|
Emeritus Members
 |
Member, BMS IAC (2000-2006)
Robert A. Millikan Professor of Biology
California Institute of Technology(2007-) President, California Institute of Technology, USA (1997-2006)
1975 Winner of the Nobel Prize in Physiology or Medicine
President of Rockefeller University, USA (1990-1991)
Founding Director, Whitehead Institute for Biomedical Research at MIT, USA (1982-1990) |
| |
|
 |
Member, BMS IAC (2001-2004)
Director, Center for Neurobiology and Psychiatry, University of California, San Francisco (UCSF), USA
Chair, Board of Scientific Counselors, National Institute of Mental Health
Chairman, Dept of Psychiatry & Director, Langley Porter Psychiatric Institute, UCSF, USA (1986-1993) |
| |
|
|
|
Member, BMS IAC, (2003-2005) Executive Director, Global HIV Vaccine Enterprise
President, Canadian Institutes of Health Research, Canada (2000-2007)
Director of Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Canada (1994-2000) |
| |
|
 |
Member, BMS IAC (2005-2007)
Chairman, A*STAR - Duke-NUS Graduate Medical School Neuroscience Research Partnership, Singapore (2007-)
Chief Executive, Medical Research Council, UK (2003-2007)
President, British Neuroscience Association (1997-2000)
President, British Association for the Advancement of Science (1997-1998) |
| |
|
 |
Member, BMS IAC (2006-)
Director & Royal Society Research Professor, School of Life Sciences, University of Dundee (1984-) |
| |
|
 |
Member, BMS IAC (2000-2004)
Kwoh-Ting Li Professor of Genetics and Professor of Medicine, Stanford University (USA)
Previous Chairman, Department of Genetics, Stanford University |
| |
|
 |
Member, BMS IAC (2000-2003)
Executive Vice President for Research, Columbia University, USA (2003-)
Chairman, Dept of Biochemistry and Molecular Biophysics, College of Physicians and Surgeons, Columbia University (1990-2003)
Interim Dean for Research, Faculty of Medicine, Columbia University (2000-2001)
Executive Vice President & Director of Research, Synergen, Inc (1984-1990) |
| |
|
 |
Member, BMS IAC (2001-2007)
President & Director, Fred Hutchinson Cancer Research Center, USA (1997-)
2001 Winner of the Nobel Prize in Physiology or Medicine |
| |
|
 |
Member, BMS IAC (2000-2006)
Chairman, Singapore Immunology Network (SIgN) (2006-)
Chair of Molecular Immunology, College de France, France (1998-)
General Director, Institut Pasteur, France (2000-2004)
Head of Research, Pasteur-Mérieux-Connaught (now Aventis-Pasteur), France (1993-1996) |
| |
|
 |
Member, BMS IAC (2003-2005)
President, The Scripps Research Institute, USA (1986-)
Chairman, Department of Molecular Biology, The Scripps Research Institute, USA (1982-1986) |
| |
|
 |
Member, BMS IAC (2003-2005)
Member, Whitehead Institute & Professor of Biology, MIT (USA)
Director, Whitehead Institute, MIT (2001-2004)
Albert D. Lasker Professor of Medical Sciences, Dept of Molecular Genetics & Cell Biology, University of Chicago (1999-2001) |
| |
|
 |
Member, BMS IAC (2000-2003)
President Emeritus, Memorial Sloan-Kettering Cancer Center, USA
President & Chief Executive Officer, Memorial Sloan-Kettering Cancer Center (1980-1999)
VP for Health Sciences & Director, Comprehensive Cancer Center, (1973-1980) & Dean, Faculty of Medicine (1970-1973), Columbia University |
| |
|
 |
Co-Chairman, BMS IAC (2004-2007)
President, University of Texas M.D. Anderson Cancer Center, USA (1996-) Chairman, Department of Medicine, Memorial Sloan Kettering Cancer Center, USA (1985-1996) |
| |
|
 |
Member, BMS IAC (2000-2003)
Former Master of Christ’s College, University of Cambridge, UK
Master of Christ's College, University of Cambridge (1995-2002)
Founder, Cantab Pharmaceuticals plc (1989-1995) |
| |
|
 |
Member, BMS IAC (2000-2004)
Chairman, A*STAR Graduate Academy International Advisory Panel
Regius Professor of Physics, School of Clinical Medicine, University of Cambridge, UK (1987-2005)
Head, School of Clinical Medicine & Honorary Consultant Physician, Addenbrooke's NHS Trust, University of Cambridge |
| |
|
 |
Member, BMS IAC (2003-2005)
Chairman, Biomedical Research Council, A*STAR
Chairman, Singapore Bioimaging Consortium (2005-)
Professor and Head
Department of Physiology
Anatomy and Genetics
University of Oxford (2005-) |
| |
|
 |
Member, BMS IAC (2004-2006)
President & CEO, The Burnham Institute, USA (2002-)
Scientific Director, The Burnham Institute, USA (1995-2002)
Deputy Director, Burnham Institute Cancer Center, USA (1994-2002)
Scientific Co-Founder of IDUN Pharmaceuticals (1993) and GMP/Diagnostics |
| |
|
 |
Member, BMS IAC (2000-2003)
Executive Director, Garvan Institute of Medical Research, Australia (1990-)
Chairman, Australian National Health & Medical Researh Council
Chairman, Australian Genome Research Facility (2000-2003)
President (1986-1987) & DIrector of Research (1984-1986), California Biotechnology Inc. |
| |
|
 |
Member, BMS IAC (2000-2004)
Research Director, Singapore OncoGenome Project, Centre for Molecular Medicine, A*STAR (2004-)
Director, Molecular Biology, Max-Planck-Institute for Biochemie, Germany (1988-)
Founder of SUGEN Inc., USA (1991), Axxima Pharmaceuticals AG, Germany & U3 Pharma AG, Germany |
| |
|
 |
Member, BMS IAC (2000-2004)
Director, Centre for Medical Innovations, Karolinska Institute, Sweden (2004-)
President, Karolinska Institute (1995-2003)
Chief Scientific Advisor to Swedish Government (1999-)
Chairman, WHO-UNAIDS Vaccine Advisory Committee (2002)
Director General, National Bacteriological Laboratory, Sweden (1988) |
| |
|
 |
Member, BMS IAC (2004-2010)
President, Max Planck Society, Germany (2002-)
Honorary Professor, University of Göttingen, Germany (1990-) |
| |
|
 |
Member, BMS IAC, (2002-2010)
Regius Professor of Clinical Medicine, University of Oxford, UK (2002-)
Founded Oxford University's Wellcome Trust Centre for Human Genetics (1993)
Founder/Founding Director of Powderject (1993), Oxagen (1997) and Avidex (1999) |
| |
|
 |
Sir Paul Nurse
Member, BMS IAC (2010-)
President, The Royal Society UK |
|